Intra Cellular Therapies shares owned by FMR
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by FMR
from 13F filings
Historical chart of FMR investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by FMR consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by FMR
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $351M | 2.7M | 131.92 |
| 2024-12-31 | $925M | 11M | 83.52 |
| 2024-09-30 | $814M | 11M | 73.17 |
| 2024-06-30 | $770M | 11M | 68.49 |
| 2024-03-31 | $775M | 11M | 69.20 |
| 2023-09-30 | $572M | 11M | 52.09 |
| 2023-06-30 | $708M | 11M | 63.32 |
| 2023-03-31 | $647M | 12M | 54.15 |
| 2022-12-31 | $637M | 12M | 52.92 |
| 2022-09-30 | $478M | 10M | 46.53 |
| 2022-06-30 | $590M | 10M | 57.08 |
| 2022-03-31 | $670M | 11M | 61.19 |
| 2021-09-30 | $413M | 11M | 37.28 |
| 2021-06-30 | $495M | 12M | 40.82 |
| 2021-03-31 | $412M | 12M | 33.93 |
| 2020-12-31 | $382M | 12M | 31.80 |
| 2020-09-30 | $304M | 12M | 25.66 |
| 2020-06-30 | $219M | 8.5M | 25.67 |
| 2020-03-31 | $119M | 7.7M | 15.37 |
| 2019-12-31 | $217M | 6.3M | 34.31 |
| 2019-09-30 | $46M | 6.1M | 7.47 |
| 2019-06-30 | $107M | 8.3M | 12.98 |
| 2019-03-31 | $101M | 8.3M | 12.18 |
| 2018-12-31 | $94M | 8.2M | 11.39 |
| 2018-09-30 | $178M | 8.2M | 21.70 |
| 2018-06-30 | $145M | 8.2M | 17.67 |
| 2018-03-31 | $173M | 8.2M | 21.05 |
| 2017-12-31 | $119M | 8.2M | 14.48 |
| 2017-09-30 | $126M | 8.0M | 15.78 |
| 2017-06-30 | $81M | 6.5M | 12.42 |
| 2017-03-31 | $106M | 6.5M | 16.25 |
| 2016-12-31 | $98M | 6.5M | 15.09 |
| 2016-09-30 | $99M | 6.5M | 15.24 |
| 2016-06-30 | $252M | 6.5M | 38.82 |
| 2016-03-31 | $180M | 6.5M | 27.80 |
| 2015-12-31 | $347M | 6.5M | 53.79 |
| 2015-09-30 | $252M | 6.3M | 40.04 |
| 2015-06-30 | $168M | 5.2M | 31.95 |
| 2015-03-31 | $125M | 5.2M | 23.88 |
| 2014-09-30 | $60M | 4.4M | 13.71 |
| 2014-03-31 | $80M | 4.4M | 18.18 |
Top funds holding Intra Cellular Therapies
View all funds holding Intra Cellular Therapies